CTIS2023-504616-15-02进行中（未招募）1 期
Rectally administered micronized progesterone for luteal phase support in hormone replacement therapy frozen embryo transfer (HRT-FET) cycle – non-inferiority randomized controlled trial
Region Midtjylland0 个研究点目标入组 618 人开始时间: 2023年9月11日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 618
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 64（—）
入选标准
- •18-46 years, BMI >18.5 <34 kg/m², Day 5 vitrified blastocyst available for transfer after thawing, Speaking and understanding Danish
排除标准
- •Has a contraindication or history to Cyclogest or components there of; or has a history of drug or allergy that, in the opinion of the investigator contraindicates study participation., Violation of the protocol., Inflammatory bowel disease (Colitis ulcerosa and Mb. Crohn),, Endometrium <7 mm after 12-20 days of 6 mg estradiol treatment., Previous enrolment in the trial., No blastocyst for transfer., Uterine abnormalities, Oocyte donation., Dysregulated severe chronical medical diseases., Patients who are treated with medication metabolized by CYP3A4 enzymes.
研究者
相似试验
进行中（未招募）
1 期
Rectally administered micronized progesterone for luteal phase support in hormone replacement therapy frozen embryo transfer (HRT-FET) cycle – non-inferiority randomized controlled trialInfertilityCTIS2023-504616-15-00Region Midtjylland618
已完成
不适用
Subcutaneous injections of depot medroxyprogesterone acetate versus Leuprolide acetate for the reduction of pain associated with endometriosis in European and Asian women. A Phase III, randomized, parallel group, multinational, multicenter study including evaluations of bone mineral density and substudies of coagulation and lipid profiles.PER-025-01PHARMACIA & UPJOHN INTERAMERICAN CORPORATION,
招募中
不适用
Standard dose of effervescent progesterone vaginal tablet for luteal phase support in frozen embryo transfer cycleinfertilityJPRN-UMIN000021983Sanno Hospital400
已完成
2 期
The effect of progesterone to prevent preterm deliveryIRCT20091023002624N28Iran University of Medical Sciences140
已完成
2 期
Efficacy and safety of oral micronized progesterone that converts to allopregnanolone as an adjunctive treatment in refractory status epilepticus (Phase IIa study)Refractory status epilepticus (RSE) patientTCTR20200717002Phramongkutklao Hospital6